MELBOURNE, AUSTRALIA--(Marketwire - January 18, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that the current online addition of Neurobiology of Aging Journal, has published a paper titled, “Zinc and Copper Modulate Alzheimer A-beta Levels in Human Cerebrospinal Fluid,” which further supports Prana’s scientific approach in the treatment of Alzheimer’s Disease.
